查看購物車
  • English
封面
市場調查報告書
商品編碼
1902080

即時螢光定量PCR、數位螢光定量PCR和終點螢光定量PCR市場－全球產業規模、佔有率、趨勢、機會和預測，按技術、產品、應用、地區和競爭格局分類，2021-2031年預測

Real-time PCR, Digital PCR & End-point PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology, By Product, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球即時螢光定量PCR、數位PCR和終點PCR市場規模將從2025年的90.1億美元成長到2031年的131.2億美元，複合年成長率為6.46%。該市場涵蓋了用於精確檢測和定量遺傳物質的先進核酸擴增技術。即時螢光定量PCR可實現即時監測，數位PCR可提供絕對定量，而終點PCR仍是定性分析的基礎。

市場概覽
預測期 2027-2031
市場規模：2025年 90.1億美元
市場規模：2031年 131.2億美元
複合年成長率：2026-2031年 6.46%
成長最快的細分市場 臨床
最大的市場 北美洲

主要市場促進因素

全球傳染病和遺傳性疾病的日益普及是推動市場發展的主要因素，也因此需要高通量、高靈敏度的診斷工具。隨著癌症等慢性疾病負擔的加重，人們越來越依賴即時和數位PCR技術進行生物標記定量和基因突變分析，以支持早期檢測和個人化治療策略。

主要市場挑戰

發展中地區高昂的儀器成本和有限的診斷基礎設施嚴重阻礙了全球即時螢光定量PCR、數位螢光定量PCR和終點螢光定量PCR市場的成長。先進的分子平台需要大量的設備前期投入和持續的耗材費用，這對於低收入地區的醫療系統而言是難以負擔的。

主要市場趨勢

用於檢測多種病原體的多重PCR檢測方法的廣泛應用，顯著改變了診斷流程，因為它能夠從單一樣本中同時識別多種標靶。這一趨勢解決了重複檢測效率低下的問題，尤其適用於胃腸道感染、腦膜炎和膿毒症等複雜的臨床表現，在這些情況下，快速確定特定的致病因子對於患者管理至關重要。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球即時PCR、數位PCR與終點PCR市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依技術分類（定量、數位化、終端）
    • 依產品分類（耗材及試劑、儀器、軟體及服務）
    • 按應用領域（臨床、研究）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美即時PCR、數位PCR與終點PCR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲即時PCR、數位PCR與終點PCR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區即時PCR、數位PCR與終點PCR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲即時PCR、數位PCR和終點PCR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲即時PCR、數位PCR與終點PCR市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球即時螢光定量PCR、數位螢光定量PCR和終點螢光定量PCR市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Abbott Laboratories Inc
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific, Inc.
  • BIOMERIEUX SA
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Agilent Technologies, Inc.
  • Qiagen NV
  • Microsynth Ag

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16090

The Global Real-time PCR, Digital PCR & End-point PCR Market will grow from USD 9.01 Billion in 2025 to USD 13.12 Billion by 2031 at a 6.46% CAGR. The Global Real-time PCR, Digital PCR & End-point PCR Market comprises advanced nucleic acid amplification technologies utilized for the precise detection and quantification of genetic materials. While real-time PCR enables immediate monitoring and digital PCR provides absolute quantification, end-point PCR remains fundamental for qualitative analysis.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 9.01 Billion
Market Size 2031USD 13.12 Billion
CAGR 2026-20316.46%
Fastest Growing SegmentClinical
Largest MarketNorth America

Key Market Drivers

The escalating global prevalence of infectious diseases and genetic disorders acts as a primary catalyst for the market, necessitating high-throughput and highly sensitive diagnostic tools. As the burden of chronic conditions like cancer intensifies, the reliance on real-time and digital PCR for biomarker quantification and genetic mutation analysis has surged to support early detection and personalized treatment strategies.

Key Market Challenges

High instrumentation costs and limited diagnostic infrastructure in developing regions significantly hinder the growth of the Global Real-time PCR, Digital PCR & End-point PCR Market. Advanced molecular platforms require substantial upfront capital for equipment and continuous funding for consumables which proves prohibitive for healthcare systems in low-income areas. These financial barriers prevent the widespread installation of PCR platforms in decentralized laboratories and confine the market largely to well-funded urban centers.

Key Market Trends

The proliferation of multiplex PCR assays for syndromic pathogen detection is significantly altering diagnostic workflows by enabling the simultaneous identification of numerous targets from a single specimen. This trend addresses the inefficiency of serial testing, particularly for complex clinical presentations such as gastrointestinal infections, meningitis, and sepsis, where identifying the specific causative agent rapidly is critical for patient management.

Key Market Players

  • Abbott Laboratories Inc
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific, Inc.
  • BIOMERIEUX SA
  • Fluidigm Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Agilent Technologies, Inc.
  • Qiagen NV
  • Microsynth Ag

Report Scope:

In this report, the Global Real-time PCR, Digital PCR & End-point PCR Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Real-time PCR, Digital PCR & End-point PCR Market, By Technology:

  • Quantitative
  • Digital
  • Endpoint

Real-time PCR, Digital PCR & End-point PCR Market, By Product:

  • Consumables & Reagents
  • Instruments
  • Software & Services

Real-time PCR, Digital PCR & End-point PCR Market, By Application:

  • Clinical
  • Research

Real-time PCR, Digital PCR & End-point PCR Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Real-time PCR, Digital PCR & End-point PCR Market.

Available Customizations:

Global Real-time PCR, Digital PCR & End-point PCR Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Quantitative, Digital, Endpoint)
    • 5.2.2. By Product (Consumables & Reagents, Instruments, Software & Services)
    • 5.2.3. By Application (Clinical, Research)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Product
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Application

7. Europe Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Application
    • 7.3.2. France Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Application

8. Asia Pacific Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Application
    • 8.3.2. India Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Application

9. Middle East & Africa Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Application
    • 9.3.2. UAE Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Application
    • 9.3.3. South Africa Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Application

10. South America Real-time PCR, Digital PCR & End-point PCR Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Application
    • 10.3.2. Colombia Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Application
    • 10.3.3. Argentina Real-time PCR, Digital PCR & End-point PCR Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Real-time PCR, Digital PCR & End-point PCR Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Bio-Rad Laboratories Inc.
  • 15.3. Thermo Fisher Scientific, Inc.
  • 15.4. BIOMERIEUX SA
  • 15.5. Fluidigm Corporation
  • 15.6. F. Hoffmann-La Roche Ltd
  • 15.7. GE Healthcare
  • 15.8. Agilent Technologies, Inc.
  • 15.9. Qiagen NV
  • 15.10. Microsynth Ag

16. Strategic Recommendations

17. About Us & Disclaimer